Clinical trials
Asthma clinical trials
A condition where the airways narrow and swell, making breathing difficult. We’re tracking 385 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03984253Recruiting
Swiss Severe Asthma Register for adults and children
This study set up a long-term asthma registry to better understand people with severe asthma and what treatments they use. If you fit the asthma severity requirements, you may be asked for consent and basic health information so the team can follow your asthma over time.
Liestal, Basel-LandschaftAges 1 year+ - NCT07313904Recruiting
Fungal exposure and lung health study
This study looks at how environmental fungi (mold) affect lung function and asthma. Researchers need healthy volunteers without lung disease to compare results.
Ningbo, ZhejiangAges 18–80 - NCT07309614RecruitingPhase 3
Dupilumab for asthma remission
This trial tests whether dupilumab, a medicine that helps reduce airway inflammation, can help people with asthma achieve remission. You may be eligible if you have asthma with high markers of inflammation and have had asthma attacks despite using your regular inhaler.
Nedlands, Western AustraliaAges 18–79 - NCT07301736RecruitingPhase 2
New asthma inhaler study for mild to moderate asthma
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
Buenos AiresAges 18–75 - NCT07301255RecruitingPhase 2
ENV-294 for moderate-to-severe asthma in adults
This trial tests an experimental drug called ENV-294 in adults with moderate-to-severe asthma. You may join if you are already using two kinds of inhalers regularly and have had at least one asthma flare-up in the past year that needed steroids or a hospital visit.
Birmingham, AlabamaAges 18–75 - NCT07280364Recruiting
Using blood tests to understand asthma in kids
This study uses a special blood test (metabolomics) to better understand asthma in children and help guide treatment. It may help find out more about your child's asthma and how to manage it.
MoscowAges 12–17 - NCT07276724RecruitingPhase 3
Study of GB-0895 for severe uncontrolled asthma
This study tests a new medicine called GB-0895 for people with severe asthma that is not well controlled by current treatments. The medicine is added to your usual asthma medications to see if it can reduce asthma attacks and improve breathing.
Northridge, CaliforniaAges 12–80 - NCT05831566RecruitingPhase 3
Digital coaching program for severe asthma control
This Phase 3 study tests whether an asthma care program with digital (phone-based) support helps people with severe asthma stay more stable and manage symptoms better. You may need to meet specific criteria for “severe, refractory” asthma and be willing to use a smartphone for monitoring and coaching.
Rotterdam, South HollandAges 18 years+ - NCT04380038RecruitingPhase 4
Viral infection study in well-controlled asthma adults
This study looks at how a viral infection affects people with well-controlled asthma. It tests whether specific asthma-related immune signals can predict who reacts more to a virus, which may help guide future asthma care.
Charlottesville, VirginiaAges 18–40 - NCT07245576Recruiting
Testing new ways to diagnose asthma and COPD in primary care
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
Buenos AiresAges 18 years+ - NCT07241546RecruitingPhase 2
Inhaled study drug for people with mild allergic asthma
This trial tests an inhaled drug called ARO-RAGE to see if it can help people with mild asthma who have allergies. You'll take the drug and then do a special breathing test to see how your lungs respond.
Vancouver, British ColumbiaAges 18–65 - NCT07245368RecruitingPhase 1/Phase 2
Testing a new asthma drug in healthy people and those with asthma
This study tests an investigational drug called PRA-216, first in healthy volunteers to check safety, then in people with mild-to-moderate asthma to see if it helps control symptoms. It's an early-stage trial to find out if the drug is safe and works.
Botany, New South WalesAges 18–65 - NCT07241117RecruitingPhase 4
Community health center asthma support study
This study tests a new way to help manage asthma in community health centers. If you have moderate to severe asthma, you may be able to join and get extra support to improve your asthma control.
St Louis, MissouriAges 12 years+ - NCT06239844Recruiting
Asthma guidance for non-English speaking families
This study helps families who speak a language other than English manage their child's asthma better. It connects you with a guide who supports your family in navigating asthma care and improving your child's breathing.
Aurora, ColoradoAges 4–89 - NCT07224061Recruiting
Asthma management program using technology and care coordination
This trial uses a smartphone app and care coordination to help children ages 4–12 with uncontrolled asthma. It aims to improve asthma control and reduce symptoms by connecting clinics and schools.
The Bronx, New YorkAges 4–12 - NCT07214753Recruiting
Benralizumab for severe eosinophilic asthma in Italy
This study follows people with severe eosinophilic asthma who are starting benralizumab. It looks at how well the treatment works in real life, outside of a controlled research setting.
Salerno, BattipagliaAges 18 years+ - NCT07219173RecruitingPhase 2
Study of brenipatide for uncontrolled moderate to severe asthma
This study tests an investigational drug called brenipatide for people with moderate to severe asthma that isn't well controlled by current medicines. The purpose is to see if it can reduce asthma attacks better than a placebo (inactive treatment).
Tempe, ArizonaAges 18–75 - NCT05028153RecruitingPhase 2
Azithromycin for young children with asthma-like hospital symptoms
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
Gentofte MunicipalityAges 1 year–5.9 years - NCT06837922RecruitingPhase 3
Study of MG-K10 for moderate to severe asthma
This trial tests a new drug called MG-K10 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if the drug can reduce asthma attacks and improve breathing. You may be able to join if you have had asthma for at least a year, use high-dose inhalers plus another controller medicine, and have had a recent flare-up.
Guangzhou, GuangdongAges 12–75 - NCT07196436Recruiting
Air cleaner and ventilation study for asthma
This study tests if improving home ventilation and adding air cleaners can help manage asthma symptoms. It's for adults and children with asthma who own their home in the Dallas-Fort Worth area.
Arlington, TexasAges 5 years+ - NCT06015256Recruiting
Natural killer cells in severe asthma patients
This study looks at immune cells called natural killer cells in people with severe asthma. Researchers want to see how these cells are different in people whose asthma is well-controlled, not well-controlled, or flaring up, compared to healthy volunteers without asthma.
MarseilleAges 18 years+ - NCT07189806Recruiting
Asthma study tracking symptoms over 5 years
This study follows adults with mild, moderate, or severe asthma to better understand the condition. You'll attend regular check-ups at the clinic to monitor your lung function and symptoms over five years.
LondonAges 18 years+ - NCT07183657Recruiting
Tracking inhaler use in lung disease
This study looks at how well people with COPD or asthma use their inhalers. It aims to understand common problems and find ways to improve treatment adherence.
Hradec KrálovéAges 18 years+ - NCT07168473RecruitingPhase 3
A study of DW1807 for year-round allergies and asthma
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
SeoulAges 19 years+
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma?
- Yes. Clin2 currently lists 385 recruiting asthma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.